Oncology Research Open Access Editors-in-Chief: Edward Chu, Enrico Mini
Home Oncology Research All Issues Volume 33 Issue 3
Volume 33 Issue 3, February 2025
PP. 505-739
|
22 articles
Review
Review | Open Access
T-cell prolymphocytic leukemia, a case report and review of the literature
Published: 28 February 2025
2025, 33(3): 505-517
Review | Open Access
Targeting myeloid-derived suppressor cells in the tumor microenvironment: potential therapeutic approaches for osteosarcoma
Published: 28 February 2025
2025, 33(3): 519-531
Review | Open Access
Biomarkers for predicting bladder cancer therapy response
Published: 28 February 2025
2025, 33(3): 533-547
Review | Open Access
Biological roles and molecular mechanism of circular RNAs in epithelial-mesenchymal transition of gastrointestinal malignancies
Published: 28 February 2025
2025, 33(3): 549-566
Review | Open Access
Oncogenic and tumor-suppressive roles of Lipocalin 2 (LCN2) in tumor progression
Published: 28 February 2025
2025, 33(3): 567-575
Review | Open Access
Research progress on the role of decorin in the development of oral mucosal carcinogenesis
Published: 28 February 2025
2025, 33(3): 577-590
Review | Open Access
The regulatory role of ZFAS1/miRNAs/mRNAs axis in cancer: a systematic review
Published: 28 February 2025
2025, 33(3): 591-604
Article
Article | Open Access
Terpinen-4-ol suppresses proliferation and motility of cutaneous squamous cell carcinoma cells by enhancing calpain-2 expression
Published: 28 February 2025
2025, 33(3): 605-616
Article | Open Access
A novel prognostic scoring model based on cuproptosis identifies COMMD1 as a novel therapy target for liver hepatocellular carcinoma
Published: 28 February 2025
2025, 33(3): 617-630
Article | Open Access
Ultrasound genomics related mitochondrial gene signature for prognosis and neoadjuvant chemotherapy resistance in triple negative breast cancer
Published: 28 February 2025
2025, 33(3): 631-640
Article | Open Access
Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms
Published: 28 February 2025
2025, 33(3): 641-651
Article | Open Access
Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma
Published: 28 February 2025
2025, 33(3): 653-663
Article | Open Access
Magnetic melamine cross-linked polystyrene-alt-malic anhydride copolymer: Synthesis, characterization, paclitaxel delivery, cytotoxic effects on human ovarian and breast cancer cells
Published: 28 February 2025
2025, 33(3): 665-674
Article | Open Access
Dibenzo [a, c] phenazin-11-yl(phenyl) methanone (SBLJ23), a novel selective inhibitor targeting JAK2V617F mutation in myeloproliferative neoplasms
Published: 28 February 2025
2025, 33(3): 675-685
Article | Open Access
Preventive effects of low-dose radiation and hypofractionated radiation plus anti-programmed cell death protein 1 on lung metastasis in breast cancer
Published: 28 February 2025
2025, 33(3): 687-694
Article | Open Access
ICAT mediates the inhibition of stemness and tumorigenesis in acute myeloid leukemia cells induced by 1,25-(OH)2D3
Published: 28 February 2025
2025, 33(3): 695-708
Article | Open Access
CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition
Published: 28 February 2025
2025, 33(3): 709-722
Article | Open Access
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer
Published: 28 February 2025
2025, 33(3): 723-731
Retraction
Retraction | Open Access
Retraction: miR-135a confers resistance to gefitinib in non-small cell lung cancer cells by upregulation of RAC1
Published: 28 February 2025
2025, 33(3): 733
Retraction | Open Access
Retraction: miR-144-3p targets FosB proto-oncogene, AP-1 transcription factor subunit (FOSB) to suppress proliferation, migration, and invasion of PANC-1 pancreatic cancer cells
Published: 28 February 2025
2025, 33(3): 735
Retraction | Open Access
Retraction: miR-641 functions as a tumor suppressor by targeting MDM2 in human lung cancer
Published: 28 February 2025
2025, 33(3): 737
Retraction | Open Access
Retraction: MYBL2 is targeted by miR-143-3p and regulates breast cancer cell proliferation and apoptosis
Published: 28 February 2025
2025, 33(3): 739